Project Details
| Status | Active |
|---|---|
| Effective start/end date | 10/12/22 → 10/12/25 |
Funding
- Memorial Sloan Kettering Cancer Center ((OE) Prot #NU MSK20H06 // (OE) Prot #NU MSK20H06)
- Pharmacyclics, Inc. ((OE) Prot #NU MSK20H06 // (OE) Prot #NU MSK20H06)
Prot #NU MSK20H06: A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase III Study of Ibrutinib in Combination With Rituximab in Subjects With Treatment Naïve Marginal Zone Lymphoma
- Ma, Shuo (PD/PI)
Project: Research project